about
Acid beta-glucosidase 1 counteracts p38delta-dependent induction of interleukin-6: possible role for ceramide as an anti-inflammatory lipidPaleopathological description and diagnosis of metastatic carcinoma in an Early Bronze Age (4588+34 Cal. BP) forager from the Cis-Baikal region of Eastern SiberiaS100A7-downregulation inhibits epidermal growth factor-induced signaling in breast cancer cells and blocks osteoclast formation.Systemic radionuclide therapy in pain palliation.Recent advances in antimultiple myeloma drug development.Roles of interleukin-6 and parathyroid hormone-related peptide in osteoclast formation associated with oral cancers: significance of interleukin-6 synthesized by stromal cells in response to cancer cells.Fine needle aspiration biopsy of an osteoclast-rich undifferentiated urothelial carcinoma: A cytology case report and review of the literature.The molecular classification of multiple myelomaHow I treat smoldering multiple myeloma.The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid tumorsActivation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.Zoledronic acid (Zometa) use in bone disease.Dkk-1 and IL-7 in plasma of patients with multiple myeloma prevent differentiation of mesenchymal stem cells into osteoblastsOsteoporosis in chronic obstructive pulmonary diseaseThe type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling.Bone marrow as a metastatic niche for disseminated tumor cells from solid tumors.A Two-Step Pretargeted Nanotherapy for CD20 Crosslinking May Achieve Superior Anti-Lymphoma Efficacy to RituximabLansoprazole as a rescue agent in chemoresistant tumors: a phase I/II study in companion animals with spontaneously occurring tumors.Can Zoledronic Acid be Beneficial for Promoting Tumor Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy?Production and Functional Characterization of Murine Osteoclasts Differentiated from ER-Hoxb8-Immortalized Myeloid Progenitor CellsA novel animal model for bone metastasis in human lung cancer.Thiocolchicoside suppresses osteoclastogenesis induced by RANKL and cancer cells through inhibition of inflammatory pathways: a new use for an old drug.Gorham-Stout disease of the proximal fibula treated with radiotherapy and zoledronic acid.Surface-tension driven open microfluidic platform for hanging droplet culture.Mortality following bone metastasis and skeletal-related events among patients 65 years and above with lung cancer: A population-based analysis of U.S. Medicare beneficiaries, 1999-2006.Neural progenitor cell-mediated delivery of osteoprotegerin limits disease progression in a preclinical model of neuroblastoma bone metastasisPathobiology and management of prostate cancer-induced bone pain: recent insights and future treatments.Malignant myeloma in a patient after treatment for osteoporosis with teriparatide; a rare coincidenceA prospective study of bone tumor response assessment in metastatic breast cancer.The role of the insulin-like growth factor 1 receptor axis in multiple myeloma.Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma.Osteoimmunology and Beyond.Biocompatibility and characterization of a Kolsterised(®) medical grade cobalt-chromium-molybdenum alloy.FMS Kinase Inhibitors: Current Status and Future Prospects.Obstructive sleep apnea and cancer: effects of intermittent hypoxia?Bone Pain and Muscle Weakness in Cancer Patients.The effect of RCAN1 on the biological behaviors of small cell lung cancer.Interaction between bone marrow stromal cells and neuroblastoma cells leads to a VEGFA-mediated osteoblastogenesis.Dual focal adhesion kinase/Pyk2 inhibitor has positive effects on bone tumors: implications for bone metastases.Cilengitide restrains the osteoclast-like bone resorbing activity of myeloma plasma cells.
P2860
Q24320202-A5AB6FA5-058C-4999-9529-659525CCEC64Q28650445-E216A09D-A71E-4789-B5A6-B2559AAC8075Q33322536-0A6C78A4-94B1-47C5-BF2B-8175096550D6Q33369416-0BC3DDF2-6693-4628-9A05-0084FB88D96FQ33416297-CB017298-E288-45E6-BA53-459E8742FA9DQ33597248-0EBDEFA1-CEE7-4A7B-91F2-C9DA5AC4CE0CQ34201372-F2AB0B46-5C12-4EEA-AB93-5873292AF0D9Q34530992-34B23A4A-5727-4CBA-9E87-ABE1DBE6EDEFQ34580094-6137CB39-69A9-433D-A5A9-1E2E2F6C4E74Q34617864-05FEAA30-8249-47E9-BD84-19A3F5B0EC8AQ34664057-DE5056CE-1BB5-4455-8A86-B8355A8AC18FQ35117725-612A082F-4143-4D4A-890D-8F9C9474A126Q35144762-93CFB712-F258-4B5B-A949-8749CCCE8839Q35173349-2982A97C-4392-4D2F-8831-7D11ECAC5FE9Q35196305-81D3F4A9-F1EB-4FDB-B087-6293538F8F3CQ35632622-7ECB4838-6CF4-4D30-8114-BFAAC762108BQ35633346-5FDF18A9-49D6-4793-87F0-2219091070F2Q35690150-A091728A-949E-4890-B567-0B2DA580C2A1Q35750453-BEDB4619-5EA1-48B9-B204-EFB912212158Q35830567-DACE3C46-1C56-4898-A1EE-B8A6E7FCEBF1Q35995127-6B0C65F7-C737-474A-B3A6-F3CB528ED2B2Q36147288-824FD8AF-56F5-4F61-A8D1-EB29EE0BDE73Q36207586-777AAB25-4819-4CF8-B060-9F57856864CAQ36462782-88B3D042-8403-4C9A-AFD1-BEC9E71E74D1Q36817898-CB74B0B2-9C4C-4642-B79A-8E61CD901DF8Q37127171-39D209A8-4693-4D0D-BE8C-5A680BB673CCQ37187646-EC5C33C0-4E4E-4291-A3B2-10C41EB3F741Q37202913-F901F87C-BCE9-4124-AA69-2FF22E299160Q37393126-41FE8FAB-AEAF-46AD-B992-B72C5F3A2D2FQ37398728-0E632B95-D2DA-476C-82C9-20011158828DQ37415048-DA34A7CC-663F-4581-BEA9-B6F2406E8D28Q37548012-93BE1B9F-6917-4483-95B3-E30EE6ECFB2AQ37644509-A1C2AB0C-65D0-400B-A1D4-5040DCC34C20Q37995562-7F165941-F9DF-4006-ABCA-8669DADD3C69Q38631730-55DB59BE-023D-4493-8DE6-D665C1A6FC7BQ38684768-A7A0ED08-3DBD-4992-A6A9-DAD6F7867037Q38699703-56BE7AEF-C9FA-4064-9C3E-A14966C5B36AQ38913336-936B7AA7-8BDE-4ED0-BABD-E42ED688D8B0Q40001204-46AD1B48-3788-42A3-BCCA-8CC26490E0C4Q40147550-0C6522F9-D0A8-4485-B163-4DD469E8DAB9
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Biology of osteoclast activation in cancer.
@ast
Biology of osteoclast activation in cancer.
@en
Biology of osteoclast activation in cancer.
@nl
type
label
Biology of osteoclast activation in cancer.
@ast
Biology of osteoclast activation in cancer.
@en
Biology of osteoclast activation in cancer.
@nl
prefLabel
Biology of osteoclast activation in cancer.
@ast
Biology of osteoclast activation in cancer.
@en
Biology of osteoclast activation in cancer.
@nl
P1476
Biology of osteoclast activation in cancer.
@en
P2093
G D Roodman
P304
P356
10.1200/JCO.2001.19.15.3562
P407
P577
2001-08-01T00:00:00Z